Your browser doesn't support javascript.
loading
Advances and current status of stem cell transplantation in treatment of hematological malignancies in China / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma ; (12): 485-489, 2019.
Article in Chinese | WPRIM | ID: wpr-751429
ABSTRACT
Since the founding of the People's Republic of China, much progress has been made in the field of stem cell transplantation by Chinese scholars. From the successful treatment of the first case with syngeneic bone marrow transplantation to the international original establishment of T-cell-replete haploidentical blood and marrow transplant system (known as the "Beijing Protocol"). The transformation of hematopoietic stem cell transplantation from "follow-up" to "lead-up" has been realized, and the problem of donor source has been basically solved. This article summarized the development status of stem cell transplantation in treatment of hematological malignancies in China, and the challenges that need to be addressed.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Journal of Leukemia & Lymphoma Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Journal of Leukemia & Lymphoma Year: 2019 Type: Article